Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel.

Erica Quaquarini Daniela D'Ambrosio F Sottotetti Francesca GallivanoneM HodolicP Baiardi Raffaella Palumbo Cecilia Vellani C Canevari Antonio Bernardo Isabella CastiglioniC PortaGiuseppe Trifirò

Published in: Contrast media & molecular imaging (2019)

Semi-quantitative indices such as SMATV and STLA at baseline have a prognostic role in patients treated with docetaxel for mCRPC, suggesting a potential role of 18F-FCH PET/CT imaging in clinical decision-making.

Keyphrases

pet ct
prostate cancer
decision making
high resolution
locally advanced
positron emission tomography
squamous cell carcinoma
radical prostatectomy
small cell lung cancer
human health
radiation therapy
computed tomography
rectal cancer